Clinical trials of Spanish tuberculosis vaccine MTBVAC begin in India
Bharat Biotech has started Phase 3 trials of the first live attenuated vaccine of Mycobacterium TB isolated from a human strain, Spanish biopharma firm Biofabri has completed Phase 1-2 in other countries
No comments:
Post a Comment